Articles Tagged With:
-
COVID-19 Affected U.S. Life Expectancy: How Bad Is It?
The pandemic dinged the average, but the latest data do not tell the whole story.
-
Reversal of Direct Oral Anticoagulants
Given the growing use of direct oral anticoagulants, particularly in the elderly population, it is important as an emergency physician to be well versed on the methods of emergent reversal of these agents in the bleeding patient.
-
One Dose, Lower Temps May Suffice for Pfizer/BioNTech COVID-19 Vaccine
Encouraging new data emerge regarding storage, administration requirements.
-
U.K. Approves First COVID-19 Human Challenge Trial
Volunteers will be infected with virus so researchers can learn more about pathology, speed effective vaccine development.
-
Prominent Pastor, Scientists, Researchers Seek to Ease Vaccine Fears in Minority Populations
Minority populations are more likely to participate in clinical research activities when they are encouraged by trusted authority figures, such as family physicians or pastors. One such pastor and author, Bishop T.D. Jakes of The Potter’s House in Dallas, decided to use his popular YouTube channel to broadcast information about the COVID-19 vaccine to dispel myths and to encourage his followers to take the shots.
-
IRB Improves and Simplifies Board Meeting Minutes Process
An IRB revised its board meeting minutes process from a clunky system of writing everything into an electronic document to one in which the minutes are automatically populated through the IRB’s electronic system, saving staff time and work. The old way of creating board meeting minutes sometimes took as long as a month for IRB staff to generate. Since the IRB revised its process, the staff can generate board meeting minutes within a week.
-
IRB Reduces Student Study Review Time from 65 Days to 8 Days
It is possible to shorten IRB review time dramatically, but it requires some resources and time. The IRB of Northcentral University serves a nontraditional population of students, some of whom want to complete a research study as part of their academic plan. The IRB’s streamlining process reduced the submission-to-approval time to eight days, down from an average of 65 days before the new process, according to new, unpublished data.
-
Researchers and IRBs Reconsider Minimal Risk After Trial Results
A clinical trial that involved studying electronic health record alerts for acute kidney injury seemed to be minimal risk to both the researchers and the IRBs that approved it. However, when two hospitals involved in the study reported an increased mortality rate, the researchers and the IRBs reconsidered what is truly minimal risk in these types of studies.
-
Study Shows Research Programs and IRBs Responded Quickly to the Pandemic
Human research protection programs and IRBs nationwide responded quickly and efficiently to changing processes and policies during the early months of the COVID-19 pandemic, according to the results of a recent study.
-
Infectious Disease Alert Updates
Outcome of Coccidioidomycosis in the Pre-Antifungal Era; PET Imaging for Fever of Unknown Origin; High Rates of Thromboembolism in COVID-19